Defining diastolic dysfunction post-Fontan: Threshold, risk factors, and associations with outcomes
Tarek Alsaied1, Runjia Li2, Haley Grant2
1Heart Institute, UPMC Children's Hospital of Pittsburgh, Department of Pediatrics, Division of Cardiology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Insights
Diastolic dysfunction (DD) after Fontan procedure, indicated by elevated end-diastolic pressure (EDP) >13 mm Hg, significantly increases adverse outcomes. Risk factors include older age, higher BMI, and non-left ventricular morphology.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Congenital Heart Disease
Background:
- Patients with single ventricle physiology post-Fontan procedure face high risks of diastolic dysfunction (DD) and elevated end-diastolic pressure (EDP).
- Early identification and management of DD are crucial for improving long-term outcomes in this population.
Purpose of the Study:
- To establish the optimal EDP threshold indicative of adverse outcomes following the Fontan procedure.
- To identify clinical and imaging predictors associated with the development of DD in Fontan patients.
Main Methods:
- Utilized data from the Fontan Outcome Registry using Cardiac Magnetic Resonance Examinations (FORCE).
- Included patients who underwent cardiac catheterization and cardiac magnetic resonance (CMR) within a two-year window.
- Defined a composite outcome including mortality, arrhythmias, plastic bronchitis, protein-losing enteropathy, or transplant listing.
Main Results:
- Analyzed 861 patients (mean age 16.4 ± 9.3 years); DD was defined at an optimal EDP threshold >13 mm Hg.
- Diastolic dysfunction (DD) was present in 11.3% of patients and was associated with a >3-fold increased risk of adverse outcomes (HR 3.37).
- Predictors of DD included older age at catheterization, higher BMI, non-left ventricular morphology, and larger ventricular end-diastolic volume (EDV).
Conclusions:
- Elevated EDP >13 mm Hg signifies diastolic dysfunction (DD) and is linked to a significantly higher risk of adverse outcomes post-Fontan.
- Older age, higher BMI, non-left ventricular morphology, and increased EDV are key risk factors for DD.
- Screening catheterization in patients with risk factors may aid in early DD detection and tailored management strategies.
Background:
Following the Fontan procedure, patients with single ventricle physiology are at high risk of diastolic dysfunction (DD) and elevated end-diastolic pressure (EDP).
Objective:
This study aims to determine (1) the optimal EDP threshold correlated with adverse outcomes post-Fontan and (2) the clinical and imaging predictors of DD.
Methods:
The study included patients from the Fontan Outcome Registry using CMR Examinations (FORCE) who underwent cardiac catheterization and cardiac magnetic resonance (CMR) within a 2-year window. The composite outcome was defined as all-cause mortality, sustained atrial or ventricular arrhythmia, plastic bronchitis, protein-losing enteropathy, or listing for transplantation. The EDP cutoff was determined using the lowest Brier score from Cox proportional hazard models.
Results:
The study included 861 patients (mean age 16.4 ± 9.3 years). Mean EDP was 9.0 ± 3.5 mm Hg, with DD defined at an optimal EDP threshold >13 mm Hg. Patients were followed for a median of 3.6 years after catheterization. By univariable analysis patients with DD were more likely to have Fontan associated liver disease (40% vs 29%, P = .03) and kidney disease (19% vs 6%, P < .001). In multivariable analyses, DD was associated with the composite outcome (HR 3.37, 95% CI: 2.03-5.59, P < .001). Ninety-seven patients (11.3%) had DD. Multivariable analysis demonstrated that older age at catheterization, greater body mass index (BMI), nonleft ventricular morphology, and higher ventricular end-diastolic volume (EDV) were associated with DD.
Conclusion:
DD, defined as an EDP >13 mm Hg, is linked to over 3-fold higher risk of adverse outcomes. Risk factors for DD include older age, higher BMI, nonleft ventricular morphology, and larger EDV. The presence of risk factors may warrant screening catheterization to identify DD and modify care accordingly.
More Related Videos
04:48Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Mitral Regurgitation I: Introduction
Heart Failure I: Introduction
Mitral Stenosis I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
